Authors:
JOHNSON DM
DOERN GV
HAUGEN TA
HINDLER J
WASHINGTON JA
JONES RN
Citation: Dm. Johnson et al., COMPARATIVE ACTIVITY OF 12 BETA-LACTAM DRUGS TESTED AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE FROM 5 MEDICAL-CENTERS - EFFECTS OF SERUM-PROTEIN AND CAPSULAR MATERIAL ON POTENCY AND SPECTRUM AS MEASURED BY REFERENCE TESTS, Diagnostic microbiology and infectious disease, 25(3), 1996, pp. 137-141
Authors:
FUCHS PC
BARRY AL
BROWN SD
ALLEN S
DOERN G
FERRARO MJ
HARDY D
HINDLER J
JENKENS S
MCLAUGHLIN J
MURRAY P
SEWELL D
Citation: Pc. Fuchs et al., SURVEY OF ANTIMICROBIAL ACTIVITY OF 4 COMMONLY USED 3RD-GENERATION CEPHALOSPORINS TESTED AGAINST RECENT BACTERIAL ISOLATES FROM 10 AMERICANMEDICAL-CENTERS, AND ASSESSMENT OF DISK DIFFUSION TEST-PERFORMANCE, Diagnostic microbiology and infectious disease, 24(4), 1996, pp. 213-219
Authors:
WORTH S
ERWIN ME
JONES RN
WANGER A
WASHINGTON JA
DOERN GV
HINDLER J
HAUGEN TH
APPELBAUM PC
JACOBS MR
MURRAY P
SEWELL D
Citation: S. Worth et al., QUALITY-CONTROL GUIDELINES FOR AMOXICILLIN, AMOXICILLIN-CLAVULANATE, AZITHROMYCIN, PIPERACILLIN-TAZOBACTAM, ROXITHROMYCIN, TICARCILLIN, TICARCILLIN-CLAVULANATE, TROVAFLOXACIN (CP-99,219), U-100592, AND U-100766 FOR VARIOUS TIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS SUSCEPTIBILITY TESTING METHODS - RESULTS FROM MULTICENTER TRIALS, Diagnostic microbiology and infectious disease, 24(2), 1996, pp. 87-91
Authors:
FUCHS PC
BARRY AL
BROWN SD
ALLEN S
BAUMAN M
BRUCKNER D
HINDLER J
DOERN G
FERRARO MJ
HARDY D
JENKINS S
MCLAUGHLIN J
MURRAY P
SEWELL D
Citation: Pc. Fuchs et al., PREVALENCE OF RESISTANCE TO 3 FLUOROQUINOLONES - ASSESSMENT OF LEVOFLOXACIN DISK TEST ERROR RATES AND SURROGATE PREDICTORS OF LEVOFLOXACIN SUSCEPTIBILITY, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1633-1639
Citation: R. Reid et al., PNEUMOCOCCAL MENINGITIS DURING THERAPY OF OTITIS-MEDIA WITH CLARITHROMYCIN, The Pediatric infectious disease journal, 14(12), 1995, pp. 1104-1105
Authors:
SWENSON JM
FERRARO MJ
SAHM DF
CLARK NC
CULVER DH
TENOVER FC
CHARACHE P
HOPKINS J
HARRELL LJ
RELLER LB
HARDY D
MOELLERING RC
WILSON W
HINDLER J
Citation: Jm. Swenson et al., MULTILABORATORY EVALUATION OF SCREENING METHODS FOR DETECTION OF HIGH-LEVEL AMINOGLYCOSIDE RESISTANCE IN ENTEROCOCCI, Journal of clinical microbiology, 33(11), 1995, pp. 3008-3018
Authors:
SWENSON JM
CLARK NC
SAHM DF
FERRARO ML
DOERN G
HINDLER J
JORGENSEN JH
PFALLER MA
RELLER LB
WEINSTEIN MP
ZABRANSKY RJ
TENOVER FC
Citation: Jm. Swenson et al., MOLECULAR CHARACTERIZATION AND MULTILABORATORY EVALUATION OF ENTEROCOCCUS-FAECALIS ATCC-51299 FOR QUALITY-CONTROL OF SCREENING-TESTS FOR VANCOMYCIN AND HIGH-LEVEL AMINOGLYCOSIDE RESISTANCE IN ENTEROCOCCI, Journal of clinical microbiology, 33(11), 1995, pp. 3019-3021
Authors:
DOERN GV
JONES RN
GERLACH EH
HINDLER J
STAMAND R
Citation: Gv. Doern et al., REVISED DISK DIFFUSION INTERPRETIVE CRITERIA FOR CEFACLOR, LORACARBEF, CEFPROZIL AND CEFIXIME WHEN TESTING HAEMOPHILUS-INFLUENZAE ON HAEMOPHILUS TEST MEDIUM, European journal of clinical microbiology & infectious diseases, 13(6), 1994, pp. 481-489
Authors:
JONES RN
SADER HS
ERWIN ME
ALDRIDGE K
DOERN GV
HINDLER J
FRITSCHE TR
MURRAY PR
SEWELL D
STEIN G
WASHINGTON JA
Citation: Rn. Jones et al., UPDATE OF LOMEFLOXACIN IN-VITRO ACTIVITY AND SPECTRUM - A MULTICENTERTRIAL TESTING CONTEMPORARY PATHOGENS FOLLOWING FOOD-AND-DRUG-ADMINISTRATION VALIDATION GUIDELINES, Diagnostic microbiology and infectious disease, 20(2), 1994, pp. 93-98
Authors:
JONES RN
KEHRBERG EN
ERWIN ME
ANDERSON SC
BEAVIS K
BERMAN M
BOURBEAU P
SINNOTT J
CANAWATI H
CAVALIERI S
COCKERILL F
DELLALATTA P
DENYS G
DOERN G
FORBES B
GAMBLE S
GOODMAN N
HAUGEN T
HINDLER J
HUMPHRIES J
JOSEPHSON S
KAUFFMAN C
LIBERTINE C
MAUNEY C
METCHOCK B
MICHELSON P
MURRAY P
NEEDHAM C
OELSCHDAEGER R
PRICE M
SACEANU C
SCHWALBE R
SEGRETI J
SEWELL D
SIERRA M
SLIFKIN M
SNYDMAN D
SOUTHERN P
SPIEGEL C
STEELEMOORE L
STEIN G
STRATTON C
WANGER A
WASHINGTON J
WASILAUSKAS B
WEINSTEIN M
Citation: Rn. Jones et al., PREVALENCE OF IMPORTANT PATHOGENS AND ANTIMICROBIAL ACTIVITY OF PARENTERAL DRUGS AT NUMEROUS MEDICAL-CENTERS IN THE UNITED-STATES .1. STUDYON THE THREAT OF EMERGING RESISTANCES - REAL OR PERCEIVED, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 203-215
Authors:
BALE MJ
JONES RN
ERWIN ME
MURRAY PR
WASHINGTON JA
GERLACH EH
THORNSBERRY C
HINDLER J
DOERN GV
Citation: Mj. Bale et al., MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 65-68
Authors:
JONES RN
DOERN GV
GERLACH EH
HINDLER J
ERWIN ME
Citation: Rn. Jones et al., VALIDATION OF NCCLS MACROLIDE (AZITHROMYCIN, CLARITHROMYCIN, AND ERYTHROMYCIN) INTERPRETIVE CRITERIA FOR HAEMOPHILUS-INFLUENZAE TESTED WITHTHE HAEMOPHILUS TEST MEDIUM, Diagnostic microbiology and infectious disease, 18(4), 1994, pp. 243-249
Authors:
BALE MJ
JONES RN
MURRAY PR
WASHINGTON JA
GERLACH EH
THORNSBERRY C
HINDLER J
DOERN GV
Citation: Mj. Bale et al., QUALITY-CONTROL GUIDELINES FOR CEFDINIR, CEFEPIME, CEFETAMET, CEFMETAZOLE, CEFPODOXIME, CEFPROZIL, AND CLINAFLOXACIN (CI-960) FOR VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TESTING METHODS, Journal of clinical microbiology, 31(9), 1993, pp. 2538-2540
Citation: Sm. Novak et al., RELIABILITY OF 2 NOVEL METHODS, ALAMAR AND E-TEST, FOR DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, Journal of clinical microbiology, 31(11), 1993, pp. 3056-3057